Cover Image

International experience in determining the cost-effectiveness thresholds

The article reviews international methodological guidelines, regulatory documents and existing approaches to the determination of the costeffectiveness threshold (CeT), also known as the willingness-to-pay threshold (WTP), the threshold value of the incremental cost-effectiveness ratio (ICeR), in eu...

Full description

Saved in:

Bibliographic Details
Main Authors:	T. P. Bezdenezhnykh (Author), N. Z. Musina (Author), V. K. Fedyaeva (Author), T. S. Tepcova (Author), V. A. Lemeshko (Author), V. V. Omelyanovsky (Author)
Format:	Book
Published:	IRBIS LLC, 2019-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Determination of a willingness-to-pay threshold and decision-making in financing the healthcare technologies
by: T. S. Teptsova, et al.
Published: (2018)

The concept of multi-criteria analysis of decision-making in the current system of health technology assessment in Russia
by: V. V. Omelyanovsky, et al.
Published: (2018)

IMPROVEMENT OF PRICE REGULATION FOR INNOVATIVE MEDICINES COVERED BY THE NATIONAL BUDGET
by: V. A. Lemeshko, et al.
Published: (2018)

Introduction of medical products into healthcare practice and costs reimbursement: European experience
by: V. V. Omelyanovsky, et al.
Published: (2018)

Evaluation of the reference value of the incremental parameter "cost-effectiveness" for Russian healthcare system
by: T. S. Teptsova, et al.
Published: (2021)

THE USE OF QALY AS AN INTEGRAL MEASURE OF EFFECTIVENESS IN THE EVALUATION OF MEDICAL TECHNOLOGIES
by: N. Z. Musina, et al.
Published: (2017)

Evaluation of the antitumor drugs therapeutic value using the method of multicriterial analysis of decision-making
by: V. A. Lemeshko, et al.
Published: (2020)

Review of the current approaches to the assessment of the drug innovative potential worldwide
by: N. Z. Musina, et al.
Published: (2017)

ECONOMIC JUSTIFICATION FOR TELEHEALTH TECHNOLOGY USE FOR PREVENTIVE MEDICAL EXAMINATION OF THE POPULATION IN REMOTE REGIONS
by: D. V. Fedyaev, et al.
Published: (2015)

ANALYSIS OF GOVERNMENT PROCUREMENTS OF MEDICINES APPLIED IN RARE DISEASES THERAPY
by: D. V. Fedyaev, et al.
Published: (2015)

Evolution of healthcare provider payment mechanisms
by: V. V. Omelyanovskiy, et al.
Published: (2020)

Medical care of ambulatory patients and its assessment: a review of international experience
by: D. V. Lukyantseva, et al.
Published: (2018)

Treatment of patients with malignant lymphoproliferative diseases in the Russian Federation: analysis of the data from 75 regions
by: G. R. Hachatryan, et al.
Published: (2019)

Affordability of in vivo gene therapy. Problems and potential solutions
by: V. V. Omelyanovskiy, et al.
Published: (2020)

THE USE OF MULTI-CRITERIAL DECISION ANALYSIS (MCDA) FOR ESTIMATING THE THERAPEUTIC VALUE OF INNOVATIVE DRUGS
by: V. K. Fedyaeva, et al.
Published: (2017)

Cost-Effectiveness Threshold for Healthcare: Justification and Quantification
by: Moshe Yanovskiy PhD, et al.
Published: (2022)

Concept of value-based healthcare
by: N. Z. Musina, et al.
Published: (2021)

Thresholds for the cost-effectiveness of interventions: alternative approaches
by: Elliot Marseille, et al.
Published: (2015)

Framework for developing cost-effectiveness analysis threshold: the case of Egypt
by: Ahmad N. Fasseeh, et al.
Published: (2024)

PROSPECTS FOR THE USE OF METHODS OF ECONOMIC EVALUATION AT THE STAGE OF PLANNING AND ORGANISATION OF CLINICAL TRIALS
by: N. Z. Musina, et al.
Published: (2016)

The review of the foreign experience on the financing of innovative medical technologies
by: V. V. Omelyanovskiy, et al.
Published: (2020)

EARLY HEALTH TECHNOLOGIES ASSESSMENT - NEW APPROACH TO IMPROVING THE EFFICIENCY OF THE MEDICAL TECHNOLOGY DEVELOPMENT PROCESS
by: N. Z. Musina, et al.
Published: (2016)

Acceptance of health technology assessment submissions with incremental cost-effectiveness ratios above the cost-effectiveness threshold
by: Griffiths EA, et al.
Published: (2015)

Impact of Pre-Diabetes on the Rate of Major Adverse Cardiovascular Events in Patients Undergoing Coronary Artery Bypass Grafting
by: A. N. Sumin, et al.
Published: (2018)

Approaches to determining the cost of laboratory tests
by: I. I. Khayrullin, et al.
Published: (2024)

Determinants of the Glomerular Maximal Size Threshold
by: Nobuo Tsuboi
Published: (2021)

Anaerobic threshold determination by direct blood lactate measurement without warm up protocol in female athletes
by: Mladenović-Ćirić Ivana B., et al.
Published: (2024)

Options to optimize the access to biosimilars: analysis and solutions
by: O. V. Kirsanova, et al.
Published: (2018)

Yaroslavl State Medical University on the Threshold of 75th Anniversary
by: A. V. Pavlov
Published: (2019)

The costs and cost-effectiveness of mass treatment for intestinal nematode worm infections using different treatment thresholds.
by: Andrew Hall, et al.
Published: (2009)

Current practice of organizing and financing the departmental healthcare system for the military in developed countries: a review
by: T. P. Bezdenezhnykh, et al.
Published: (2018)

Alternative method for determining anaerobic threshold in rowers
by: Giovani Dos Santos Cunha, et al.
Published: (2008)

EFFECTIVENESS OF POLYVITAMINS COMPLEX IN INFANTS WITH ORGANIC DISEASES OF INTESTINE
by: O.G. Shadrin, et al.
Published: (2010)

EFFECTIVENESS OF POLYVITAMINS COMPLEX IN INFANTS WITH ORGANIC DISEASES OF INTESTINE
by: O.G. Shadrin, et al.
Published: (2010)

Blood glucose threshold determination is stage length dependent
by: Gilmar de Jesus Esteves, et al.
Published: (2020)

APPLICATION OF MULTIPLE-CRITERIA ANALYSIS FOR OPTIMIZATION OF FINANCING OF RARE DISEASES
by: V. V. Omelyanovskiy, et al.
Published: (2015)

COST-EFFECTIVENESS EVALUATION OF PREHOSPITAL THROMBOLYSIS WITH TENECTEPLASE
by: V. V. Omel'yanovskiy, et al.
Published: (2016)

COST-EFFECTIVENESS EVALUATION OF PREHOSPITAL THROMBOLYSIS WITH TENECTEPLASE
by: V. V. Omel'yanovskiy, et al.
Published: (2016)

Cost-effectiveness analysis of using atorvastatin, simvastatin, ezetimibe, alirocumab, evolocumab, inclisiran in adults with very high cardiovascular risk under the preferential drug provision program
by: T. O. Bessonova, et al.
Published: (2023)

Methods to Estimate Willingness-to-Pay Per Quality Adjusted Life Year as Cost-Effectiveness Threshold
by: Tri Murti Andayani, et al.
Published: (2018)